GUTS SEC Filings: 8-K, 10-Q, S-3 & 424B – Fractyl Health

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

8-K

Fractyl Health Appoints Michael Wartell as Independent Director

Nov 6, 2026

8-K

Company Cuts Workforce 45%, Discontinues Rejuva Development and Focuses Resources on Revita Ahead of Planned FDA Submission

Oct 22, 2026

8-K

Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in REMAIN-1 Pivotal Study

Oct 16, 2026

8-K

Fractyl Health Announces 1-for-12 Reverse Stock Split

Oct 1, 2026

8-K

Fractyl Health, Inc. Special Meeting Results for Reverse Stock Split

Sep 24, 2026

8-K

Fractyl Health Receives Nasdaq Delisting Notice and Plans Hearing Request

Sep 11, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Sep 26, 2025

424B5

REGISTERED OFFERING

Aug 6, 2025

424B5

SHELF OFFERING | | Bank: Ladenburg Thalmann

Aug 5, 2025

424B4

OFFERING | Shares amount: 7,333,333 | Share price: $15.00 | Offering amount: $109,999,995.00

Feb 2, 2024

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jan 13, 2026

S-3/A

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

Mar 13, 2025

S-3

Form S-3 - Registration statement under Securities Act of 1933

Mar 3, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Feb 6, 2024

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Jan 29, 2024

S-1/A

INITIAL REGISTRATION FOR OFFERING | Shares amount: 7,333,333 | Share price: $15.00 EFFECTIVE

Jan 29, 2024

Proxies

TYPE

HEADLINE

FILED AT

DEF 14A

Form DEF 14A - Other definitive proxy statements

Aug 24, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Aug 14, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 24, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 24, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Aug 25, 2025

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Aug 15, 2025

Ownerships

TYPE

HEADLINE

FILED AT

Wartell Michael J. (Reporting)

Nov 6, 2026

SCHEDULE 13G

Catalio Capital Management, LP (Filed by)

Oct 13, 2026

BRADLEY WILLIAM (Reporting)

Sep 16, 2026

Royan Ajay (Reporting)

Jun 15, 2026

BRADLEY WILLIAM (Reporting)

Jun 11, 2026

Conaway Samuel (Reporting)

Jun 11, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Mar 19, 2025

CORRESP

Form CORRESP - Correspondence

Mar 13, 2025

LETTER

Form UPLOAD - SEC-generated letter

Mar 11, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Feb 2, 2024

CORRESP

Form CORRESP - Correspondence

Jan 30, 2024

CORRESP

Form CORRESP - Correspondence

Jan 30, 2024

Fractyl Health, Inc. GUTS · SEC Filings